Company
No Diabetes & Restore health
Description
Nordia Biotech & Pharmaceuticals is a spin-off company from LKS Faculty of Medicine, HKU. It was founded in December 2023 by Prof ZHOU Zhongjun, the Chui Fook-Chuen Endowed Professor from HKUMed with over 30 years of experience in development, ageing and age-associated diseases, together with his former PhD student, HE Yi, who developed the core technology. Our team members are very experienced in investment, financing, transformation and operation. Nordia Biotech finished its HKD 7M Series Angel led by HKX, and started the HKD 30M Pre-A. We received the financial support from TSSSU+ and Incu-Bio already.
Nordia Biotech targets the unmet medical needs, specifically diabetes mellitus, with functional islet organoids generated from stem cells through a self-developed, unique patented method enabling spontaneous formation of a 3D structure of islets. The islet organoids will be transplanted into the anterior sheath of the rectus abdominis muscle of patients, for long-term control of blood glucose levels by steady insulin secretion. Other products include biomaterial scaffolds to encapsulate islet organoids to increase the transplantation efficiency. The company offers islet-based contract research services, islet products as well.
